Savoir Faire Capital Management L.P. lifted its position in e.l.f. Beauty, Inc. (NYSE:ELF - Free Report) by 20.2% in the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 70,224 shares of the company's stock after purchasing an additional 11,781 shares during the period. e.l.f. Beauty accounts for about 3.9% of Savoir Faire Capital Management L.P.'s investment portfolio, making the stock its 4th biggest position. Savoir Faire Capital Management L.P. owned approximately 0.12% of e.l.f. Beauty worth $7,657,000 at the end of the most recent reporting period.
Other institutional investors also recently bought and sold shares of the company. Baillie Gifford & Co. purchased a new stake in shares of e.l.f. Beauty in the 2nd quarter worth approximately $801,693,000. Swedbank AB purchased a new stake in e.l.f. Beauty during the third quarter worth $76,321,000. Clearbridge Investments LLC boosted its position in e.l.f. Beauty by 84.4% during the 2nd quarter. Clearbridge Investments LLC now owns 1,259,644 shares of the company's stock valued at $265,432,000 after acquiring an additional 576,383 shares in the last quarter. Thrivent Financial for Lutherans increased its holdings in shares of e.l.f. Beauty by 223.2% in the 3rd quarter. Thrivent Financial for Lutherans now owns 555,287 shares of the company's stock valued at $60,543,000 after acquiring an additional 383,478 shares during the period. Finally, 1832 Asset Management L.P. bought a new position in shares of e.l.f. Beauty in the 1st quarter worth $61,299,000. 92.44% of the stock is currently owned by hedge funds and other institutional investors.
e.l.f. Beauty Stock Performance
Shares of ELF stock traded down $1.13 during trading hours on Tuesday, hitting $121.53. The company's stock had a trading volume of 2,452,265 shares, compared to its average volume of 1,919,684. The stock has a market cap of $6.85 billion, a PE ratio of 66.41, a price-to-earnings-growth ratio of 2.66 and a beta of 1.44. e.l.f. Beauty, Inc. has a 12-month low of $98.50 and a 12-month high of $221.83. The company has a 50 day moving average of $111.57 and a 200 day moving average of $153.80. The company has a current ratio of 1.78, a quick ratio of 1.01 and a debt-to-equity ratio of 0.22.
e.l.f. Beauty (NYSE:ELF - Get Free Report) last posted its quarterly earnings results on Wednesday, November 6th. The company reported $0.77 EPS for the quarter, beating the consensus estimate of $0.43 by $0.34. The company had revenue of $301.10 million for the quarter, compared to analyst estimates of $289.43 million. e.l.f. Beauty had a net margin of 8.87% and a return on equity of 19.34%. The firm's revenue was up 39.7% on a year-over-year basis. During the same period in the prior year, the company earned $0.66 earnings per share. On average, sell-side analysts forecast that e.l.f. Beauty, Inc. will post 2.8 EPS for the current fiscal year.
Insider Buying and Selling at e.l.f. Beauty
In other e.l.f. Beauty news, CEO Tarang Amin sold 23,528 shares of the company's stock in a transaction dated Thursday, September 5th. The shares were sold at an average price of $136.45, for a total value of $3,210,395.60. Following the completion of the transaction, the chief executive officer now owns 106,016 shares in the company, valued at approximately $14,465,883.20. This represents a 18.16 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. 3.50% of the stock is currently owned by corporate insiders.
Wall Street Analysts Forecast Growth
Several equities analysts have issued reports on ELF shares. B. Riley cut their target price on e.l.f. Beauty from $175.00 to $150.00 and set a "buy" rating on the stock in a research note on Thursday, November 7th. Morgan Stanley cut their price objective on shares of e.l.f. Beauty from $184.00 to $139.00 and set an "equal weight" rating on the stock in a research report on Monday, September 30th. Raymond James reissued a "strong-buy" rating and set a $235.00 target price on shares of e.l.f. Beauty in a research report on Monday, July 22nd. JPMorgan Chase & Co. cut their price target on shares of e.l.f. Beauty from $167.00 to $154.00 and set an "overweight" rating on the stock in a report on Thursday, November 7th. Finally, Bank of America lowered their price objective on e.l.f. Beauty from $190.00 to $165.00 and set a "buy" rating for the company in a research report on Tuesday, October 15th. One investment analyst has rated the stock with a sell rating, two have given a hold rating, twelve have given a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat.com, e.l.f. Beauty currently has a consensus rating of "Moderate Buy" and a consensus target price of $173.53.
Read Our Latest Analysis on ELF
About e.l.f. Beauty
(
Free Report)
e.l.f. Beauty, Inc, together with its subsidiaries, provides cosmetic and skin care products under the e.l.f. Cosmetics, e.l.f. Skin, Well People, and Keys Soulcare brand names worldwide. The company offers eye, lip, face, face, paw, and skin care products. It sells its products through national and international retailers and direct-to-consumer channels, which include e-commerce platforms in the United States, and internationally primarily through distributors.
Featured Articles
Before you consider e.l.f. Beauty, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and e.l.f. Beauty wasn't on the list.
While e.l.f. Beauty currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.